Do low testosterone, high SHBG, and postmenopausal hormone decline indicate reduced androgen bioavailability and altered cortisol output?

Clinical and Biochemical Evidence

• Androgen Bioavailability Indicated by Free and Bound Pools: Biological androgen activity depends on the balance between circulating total testosterone, free testosterone, and binding proteins. While total testosterone represents the baseline pool, free testosterone represents the unbound, biologically active fraction. Sex hormone-binding globulin (SHBG) binds circulating testosterone with high affinity. Therefore, elevated SHBG directly limits the circulating free fraction, restricting the bioavailable hormone pool.
• Co-occurring Ovarian and Adrenal Decline: Postmenopausal ovarian senescence occurs concurrently with a progressive reduction in adrenal steroidogenesis. This age-related adrenopause is characterized by a 70% to 90% reduction in circulating adrenal androgens, such as dehydroepiandrosterone (DHEA) and its sulfate (DHEA-S). This decline accelerates and plateaus post-menopause, directly overlapping with the loss of ovarian estrogen and progesterone output.

Mechanistic Explanations

• Impaired Peripheral Androgen Synthesis: A decline in adrenal DHEA/DHEA-S secretion (indicative of lower adrenal reserve) dramatically reduces the intracrine precursor pool. Because postmenopausal females rely heavily on the peripheral conversion of adrenal precursors into active androgens, this adrenal decline directly limits tissue-specific androgen bioavailability.
• Adrenal Restructuring and Enzymatic Impairment: The age-related drop in adrenal steroidogenic reserve is driven by the gradual involution of the adrenal zona reticularis, reduced ACTH-dependent pulsatility, and selective impairment of the $\Delta^5$ enzymatic pathway.
• Altered Cortisol Dynamics and HPA Axis Reactivity: The loss of estrogen and progesterone removes critical inhibitory feedback mechanisms on the HPA axis. This loss weakens glucocorticoid receptor (GR)-mediated negative feedback, resulting in heightened HPA axis sensitivity, increased peripheral conversion of cortisone to active cortisol via elevated hepatic $11\beta$-HSD1 activity, and elevated 24-hour cortisol levels. Under physical stress or direct ACTH/cosyntropin stimulation, a diminished adrenal reserve presents as an altered, blunted, or hyper-reactive cortisol response pattern.

Clinical Implications

• Shift to Glucocorticoid Dominance: The combination of decreased adrenal androgen precursors (DHEA/DHEA-S) and altered cortisol regulation shifts the systemic balance. A high cortisol-to-DHEA-S ratio is clinically associated with visceral adiposity, mood disruption, and cognitive vulnerability in postmenopausal females.

Bottom line

Low total testosterone, low free testosterone, and elevated SHBG are biochemically validated indicators of reduced androgen bioavailability. In postmenopausal females, ovarian senescence directly overlaps with a decline in adrenal steroidogenic reserve, which reduces the precursor pool for peripheral androgen synthesis and alters cortisol output by weakening HPA-axis negative feedback.